First-in-Human Experience With Sirolimus-Eluting Self-Expanding Stent for Femoropopliteal Lesions

J Am Coll Cardiol. 2019 Oct 29;74(17):2216-2218. doi: 10.1016/j.jacc.2019.08.1019.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alloys / chemistry*
  • Disease-Free Survival
  • Drug-Eluting Stents*
  • Female
  • Femoral Artery / pathology*
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Patient Safety
  • Peripheral Arterial Disease / surgery*
  • Popliteal Artery / pathology*
  • Prosthesis Design
  • Reproducibility of Results
  • Sirolimus / administration & dosage*
  • Treatment Outcome

Substances

  • Alloys
  • nitinol
  • Sirolimus